REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/29/2026
Back to search
Official data from USPTO
SYNGENE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
06/29/2026
Trademark type
Combined
Nice classes
35, 42
Filing date
08/16/2018
Registration date
06/29/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/29/2021
Last transaction
06/29/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/31/2004
First use in commerce
08/31/2004
Drawing code
5
Owner type
03
Owner location
Link Rd, Bangalore, IN
Examiner
BRACEY, KAREN
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "Syngene" in stylized font.
Holders and representatives
Holders
SYNGENE INTERNATIONAL LIMITED
Representatives
Julianne Abelman Womble Bond Dickinson (US) LLP
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business servicesformulation of best practices for drug discoveryformulation developmentclinical supplieslarge molecule developmentantibody drug conjugates and clinical development services; consulting services in the field of medical practice management for others; business consulting and management in the field of clinical trialsproviding information management services; business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; regulatory submission managementassisting others in preparing and filing applications for new drugs with governmental regulatory bodies; business management consulting services in the field of pharmaceuticals drug development; none of the aforesaid services relating to gel imaging and gel analysis applications
Class 42
Scientific research and custom synthesis; scientific and clinical research in the field of medicinepharmaceuticalnutraceuticals; scientific research and development; custom design and development of chemical reagents and biochemical assays; laboratory testing; laboratory testing services for research and development purposes; testing of pharmaceuticals; chemical engineering; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; scientific study and research in the field of reproductionhusbandrygeneral health of animal; biotechnology research for determining the neuronal survival of molecules in animal models; research and development services in the field of antibodiesantibody technology; custom design and development of chemical reagents and biochemical assays; designengineeringresearchdevelopment and testing services in the field of polymeric materialspolymer synthesismaterials customization for medicalscientifictechnological applications; toxicology services; toxicity analysis; toxicity testing for research purposes; conducting clinical trials; conducting clinical trials for scientific research for others; conducting clinical trials for pharmaceutical products; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; blood analysis services for scientific research purposes; analysis of human tissues for medical research; scientific services relating to the isolation and cultivation of human tissues and cells for research purposes; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; contract research services relating to molecular sciences; biological cloning services; structural and functional analysis of genomes; scientific and medical laboratory services; services of a chemical and/or biological laboratory; laboratory research services relating to pharmaceuticals; research and development and consultation related thereto in the field of antibodiesantibody technologychemistrybioinformaticsbiomedical devicesbiologicsbiotechnologybiotherapeuticsbiologybiochemical preparationscell linescheminformaticsgenetics and genetic engineeringgene expression systemsin vitro researchinhalation pharmaceuticalsmolecular sciencesmicro-organismsnutritionophthalmic preparationspharmacogeneticspharmacokineticspharmacologypharmaceuticalspolymerspeptide synthesisproteinsolid state characterization; toxicokinetic analysis and toxicology services; scientific and technological servicesscientific researchdevelopmentanalysistestingengineeringextractionsynthesispurification and production in the field of antibodiesactive pharmaceutical ingredients (API)biomoleculescell bank characterizationchiralitychromosome aberrationclinical chemistrycloning vectorcyclotidesDNAflow cytometrygas chromatography mass spectrometrygenesimmuno-pharmaceuticalsin vitro irritationlarge moleculeliquid chromatography mass spectrometrymicrobialsmonomersnanoparticlesnatural productspeptidesproteinsRNAsupercritical fluid chromatographysmall molecules and vaccines; none of the aforesaid services relating to gel imaging and gel analysis applicationsnone of the aforesaid services in the field of agriculturehorticulture and forestry
Publications
History of USPTO decisions and trademark events.
48 publications found
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06/02/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/02/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/02/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/02/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/02/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/02/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/02/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/29/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/28/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/27/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/26/2021
DPCC
DIVISIONAL PROCESSING COMPLETE
05/26/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/26/2021
IUAF
USE AMENDMENT FILED
05/06/2021
DRRR
DIVISIONAL REQUEST RECEIVED
05/06/2021
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
05/06/2021
EISU
TEAS STATEMENT OF USE RECEIVED
05/06/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/03/2021
EX1G
SOU EXTENSION 1 GRANTED
03/01/2021
EXT1
SOU EXTENSION 1 FILED
03/01/2021
EEXT
SOU TEAS EXTENSION RECEIVED
03/01/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/01/2020
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
07/23/2020
CHPB
POST PUBLICATION AMENDMENT - ENTERED
06/26/2020
APET
ASSIGNED TO PETITION STAFF
06/24/2020
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
06/02/2020
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
02/11/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/14/2020
PUBO
PUBLISHED FOR OPPOSITION
01/14/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/25/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/12/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/11/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/11/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/11/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/11/2019
GNRT
NON-FINAL ACTION E-MAILED
06/11/2019
CNRT
NON-FINAL ACTION WRITTEN
06/11/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/04/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/04/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/04/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/06/2018
GNRT
NON-FINAL ACTION E-MAILED
12/06/2018
CNRT
NON-FINAL ACTION WRITTEN
12/06/2018
DOCK
ASSIGNED TO EXAMINER
12/03/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/25/2018
NWAP
NEW APPLICATION ENTERED
08/20/2018
Continuous trademark protection
Get notified about every new filing that threatens SYNGENE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.